Chinese Journal of Hepatology 2005 Issue 5 More attention to targeted therapy for primary hepatocellular carcinoma

More attention to targeted therapy for primary hepatocellular carcinoma
YE Sheng-long

..............page:322-323

Congratulatory letter of the Central Committee of the CPC and State Council to the 90th anniversary of the founding of the Chinese Medical Association (CMA) and the 23rd Natonal Congress of Member Representatives of the CMA

..............page:321

Chronic hepatitis B virus infection, its treatment and prevention
ZHUANG Hui

..............page:324-325

Therapeutic strategies for hepatitis B in China: A report from the 2004 China Summit Meeting for Therapeutic Strategies of Hepatitis B
REN Hong

..............page:326-328

2004 guidelines for surgical treatment of primary hepatocellular carcinoma

..............page:329-330

Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues
SONG Hai-yan;LIU Yin-kun;CUI Jie-feng;ZHANG Li-jun;DAI Zhi;FENG Ju-tao;FENG Jiu-xian;SHEN Hua-li;YANG Peng-yuan

..............page:331-334

RNA interference-mediated silencing of MAT 2A gene attenuates growth and induces apoptosis of hepatoma cells
LIU Quan-yan;LIU Zhi-su;WU Kai-lang;ZHU Ying

..............page:335-338

Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patients' peripheral blood monocytes (PBMC) pulsed with tumor antigen
WENG Yong-qiang;QIU Shuang-jian;TANG Zhao-you;YE Sheng-long;LIU Yin-kun;FAN Jia;SUN Rui-xia;ZHAO Yan

..............page:339-342

Screening and analysis of genes encoding hepatocellular carcinoma associated tumor antigens
WANG Hong-cheng;YANG Mu-hua;SHI Yong-yu;PANG Xue-wen;YANG Xiao-ang;PENG Ji-run;LENG Xi-sheng;CHEN Wei-feng

..............page:343-346

Alteration of the malignant phenotype of human hepatocellular carcinoma cell line Hep3B by specially synthesized oligodeoxynucleotides
LI Yan;LIU Yin-kun;SHEN Yue-fang;SUN Rui-xia

..............page:347-350

Expression of MAGE-A1 in human hepatoma cell lines associated with genic hypomethylation
Xiao Jiang;CHEN Hong-song;FEI Ran;Cong Xu;WANG Yan;JIANG Dong;WEI Lai;WANG Yu

..............page:351-354

The effects of adenovirus-mediated human COX-2 antisense RNA on the growth of hepatocellular carcinoma
WANG Xiao-hu;LI Sheng-bao;XIE Guo-jian;YI Jian-hua;WU Qing-ming

..............page:355-358

Vasoinhibitory effect of Daltepartin Sodium on human hepatocellular carcinoma in nude mice
YAN Jun;ZHENG Qi;WANG Yu;LU Hong-fen;XUE Qiong;TANG Zhao-you

..............page:359-361

Binding characteristics between RGD-containing cyclic peptide and rat hepatic stellate cells: an in vitro study
DU Shi-lin;WANG Ji-yao;LU Wei-yue

..............page:362-365

A study of the association of iNOS and eNOS gene polymorphism with portal hypertension in liver cirrhosis
CHENG Yuan-qiao;LIN Ju-sheng;WANG Wen-qi;XIONG Ping;JIANG Xiao-dan

..............page:366-369

Clinical research of plasma exchange with continuous veno-venous hemofiltration in treating mid- and late-stage chronic severe viral hepatitis B patients
YE Wei-jiang;LI Lan-juan;YU Hai-yan;ZHANG Xin-ping;TIAN Jing;BAI Ming-hui

..............page:370-373

Expression of uncoupling protein 2 and its relationship to the content of adenosine triphosphate in the nonalcoholic fatty livers of rats fed a high-fat diet
FAN Jian-gao;Ding Xiao-dong;WANG Guo-liang;XU Zheng-jie;TIAN Li-yan;ZHEN Xiao-yin

..............page:374-377

The application of serum tumor markers in the diagnosis of hepatocellular carcinoma
LIAO Hui-yu

..............page:379-380

Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma
YANG Dong-hua

..............page:380-381

Therapeutic and preventive activities of lamivudine on HBV reactivation in HBV carriers with immunodeficiency
LIANG Xue-song;WAN Mo-Bin;CHEN Ji-Xiu;LI Cheng-zhong;SONG Yu;CHEN Yi

..............page:382-383

The expression of TNF-alpha and IL-1 beta in lung tissues following liver ischemia-reperfusion injury in rats
WANG Hong-mei;TANG Fei;ZHANG Jian-long;BIAN Wen-an

..............page:383-384

Study on the relationship between genotype D of hepatitis B virus and hepatocellular carcinoma
XU Zheng-ju;ZHANG Jiang-ling;YANG Hong;ZHANG Qi-hua;CHEN Xian-li

..............page:385-386

Implication of liver function in hemorrhagic fever patients with renal syndrome
WAN Bao-mei;LI He-lou;WANG Jing;WANG Hui-liang;GUO Qiang

..............page:387-388

Integration of hepatitis B virus DNA in liver tissues from patients with hepatocellular carcinoma and liver cirrhosis
ZHANG Pei-yi;WANG Yan-ying;CHENG Jun;LANG Zhen-wei;YANG Qian;ZHANG Jian-zhong;HUANG De-zhuang;YANG Yan-Jie

..............page:389-390

Expression of heparanase mRNA in ascitic cells is not a good marker in differential diagnosis of malignancies
CAI Yong-guo;FANG Dian-chun;YANG Shi-ming;LUO Yuan-hui;CHEN Ling;YANG Meng-hua;WANG Dong-xu

..............page:390-391

Treating chronic severe hepatitis B patients with mycophenolate mofetil
YANG Yong-feng;TAN De-ming;XIE Yu-tao;LU Meng-hou;LIU Zheng-bo;SHA Xin-ping;LIU Guo-zhen;WANG Ling

..............page:392-393

Hepatic veno-occlusive disease: report of two cases
CHEN Wei-Xing;YANG Ming;YU Chao-hui;LI You-ming

..............page:394-395

HGF/c-Met and metastasis of hepatocellular carcinoma
XIE Bin;DONG Jia-hong

..............page:396-398

Progress of research on cholangiocyte proliferation and apoptosis
LI Chong-hui;CHEN Ming-Yi;HUANG Zhi-qiang

..............page:399-400

di shi jie quan guo men jing mai gao ya zheng xue shu hui yi zheng wen tong zhi

..............page:350

2005 nian di er jie quan guo ren gong gan ji xue ye jing hua xue shu nian hui zheng wen tong zhi

..............page:373

zhong hua yi xue hui za zhi she dui yi gao liang tou wen ti chu li de sheng ming

..............page:398

Role and mechanism of cytokines in the carcinogenesis of liver carcinoma
Yao Deng-fu

..............page:378-379